Company Profile
Synergy Spine Solutions is a US-based manufacturer of cervical artificial disc replacement systems, headquartered in Louisville, Colorado, USA. Founded in 2005, the company operates as an independent private entity with 9 employees, serving global spine surgery markets through direct operations and distribution partnerships across Australia, Canada, Europe, Malaysia, New Zealand, South Africa, Switzerland, the UK, and the US.
Core Products ＆ Technologies
Cervical Artificial Disc Replacement
• Synergy Disc (Single-Level): FDA-approved cervical artificial disc with a built-in 6-degree lordotic core for motion preservation and sagittal alignment, indicated for C3-C7
• Synergy Disc (Two-Level): Investigational device under IDE study for two contiguous levels, fully enrolled with follow-up ongoing
Design ＆ Materials
• Lordotic Core Technology: Proprietary 6° lordotic angle designed to restore cervical alignment while preserving natural physiologic motion; available in 0° and 6° configurations
• Time-Tested Biomaterials: Nickel-free titanium alloy endplates with titanium spray coating and ultra-high molecular weight polyethylene core for long-term implant durability
Market Position ＆ Certifications
Synergy Spine Solutions holds an emerging leadership position in the global cervical total disc replacement (TDR) market, competing with Globus Medical and Zimmer Biomet. Key strengths include:
• 21 years of US engineering heritage in motion-preserving spine technologies
• Dual-Function Design: The first and only cervical disc designed to restore both motion and segmental alignment
• Clinical evidence: 87.1% composite clinical success at 24 months with superiority to fusion control (p＜0.0001); neck disability index improvement 91.7%; patient satisfaction 84.5%
• Regulatory compliance: FDA PMA approved (P250028, February 26, 2026); CE marked since 2013; commercially available in 10+ countries
• Venture backing: $30M Series A (January 31, 2024) to support clinical trials and regulatory approvals
Corporate Timeline
2005 — Founded in Louisville, Colorado, USA
2013 — Received CE marking for Synergy Disc
2024 — Closed $30M Series A financing (January 31); completed enrollment in 2-Level IDE trial
2026 — Received FDA PMA approval for single-level Synergy Disc (P250028, February 26); US commercialization initiated Spring 2026
Target Markets ＆ Applications
• Degenerative Disc Disease (DDD): Synergy Disc for symptomatic cervical DDD causing radiculopathy and/or myelopathy at one level (C3-C7)
• Motion Preservation Surgery: Alternative to anterior cervical discectomy and fusion (ACDF) for maintaining cervical range of motion
• Alignment Correction: Restoration of cervical lordosis in patients with focal sagittal malalignment via 6° lordotic core
Contact Information
Global Headquarters
Address: 357 S. McCaslin Blvd., Suite 120, Louisville, CO 80027, USA
Telephone: +1.647.692.3493
Email: info@synergyspinesolutions.com
Corporate Status
Entity Type: Independent Private Company (No Parent Company)
Stock: Not Publicly Traded
Website: synergyspinesolutions.com
